4543 On Other Exchanges
Symbol
Exchange
4543 is not on other exchanges.

terumo corp (4543) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TERUMO CORP (4543)

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical devices and pharmaceuticals worldwide. It provides products in the areas of cardiovascular, hospital, and blood systems. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro catheters and guide wires, micro balloon catheters, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and devices for percutaneous cardiopulmonary support system; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems, including infusion pumps, closed infusion systems, and IV catheters; closed anticancer drug infusion systems; drugs and devices comprising prefilled syringes and pre-fillable syringes; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices. Further, it provides analgesic and antiemetic pain management drugs; diabetes management devices; measuring device systems, such as blood glucose and blood pressure monitors, thermometers, pulse oximeters, and walking intensity and body composition monitors; and basal thermometers, fall prevention products, oral care products, urine test strips, and deodorizing devices. Additionally, the company offers automated blood collection and blood component processing systems, blood bag system with leukocyte reduction filters, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

20,697 Employees
Last Reported Date: 06/27/16
Founded in 1921

terumo corp (4543) Top Compensated Officers

Senior Executive Officer, Director, Chief Exe...
Total Annual Compensation: ¥168.0M
Compensation as of Fiscal Year 2016.
terumo corp
Terumo Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2016; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2017; Provides Dividend Guidance for the Full Year Ending March 31, 2017

Terumo Corporation reported consolidated earnings results for the nine months ended December 31, 2016. For the period, the company's net sales were JPY 374,394 million against JPY 395,991 million a year ago. Operating income JPY 58,904 million against JPY 64,115 million a year ago. Ordinary income JPY 52,204 million against JPY 60,977 million a year ago. Profit attributable to owners of parent JPY 31,822 million or JPY 81.79 per diluted share against JPY 43,484 million or JPY 107.87 per diluted share a year ago. Income before income taxes was JPY 44,621 million against JPY 65,322 million a year ago. For the year ending March 31, 2017, the company expects consolidated net sales of JPY 510,000 million, operating income of JPY 71,000 million, ordinary income of JPY 62,000 million and profit attributable to owners of parent of JPY 47,500 million or JPY 130.86 per share. The company provided dividend guidance for the full year ending March 31, 2017. For the year, the company expects to pay dividend of JPY 21.00 per share against JPY 20.00 per share paid a year ago.

Terumo Corporation Launches User Friendly PLAJEX™ Luer Lock with Threaded Closure (TC)

On the 20th Anniversary of Pharmapack, Europe's Pharmaceutical Packaging and Drug Delivery event in Paris – 1 & 2 February 2017, Terumo Corporation will showcase their latest development for PLAJEX polymer prefillable syringes. This new container closure system for luer lock syringes is very user friendly and provides patients and healthcare providers with an easy grip twist-off tip cap. The Threaded Closure (TC) has been specially designed for PLAJEX COP prefillable syringes with an integrated luer lock, combining the user friendly features with a secure connectivity, while maintaining container closure integrity. A secure and functional luer connectivity for connections in intravascular applications or hypodermic connections is of paramount importance; PLAJEX combines the design features and the robustness of an integral moulded luer lock with dimensional accuracy and functional performance. The luer cone inner bore is also designed with a large inner bore for mitigating connectivity issues with needle-free IV access devices. Contact materials are carefully selected to minimize extractables and leachables. PLAJEX polymer, ready to use syringes are steam sterilized to mitigate possible interactions with sensitive biopharmaceuticals. PLAJEX integral luer lock syringes with Threaded Closure (TC) are available for use with different syringe sizes and will feature in the future expansion of the TERUMO series of PLAJEX polymer prefillable syringe platform.

Terumo Corporation Opens Branch in Yangon

Terumo Corporation announced that its Yangon Branch opened for business in January 2017.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4543.
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 40.4x
Price/Sales 2.9x
Price/Book 2.7x
Price/Cash Flow 39.3x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.